Depression, cardiometabolic function and left ventricular hypertrophy in African men and women: the SABPA study
Nyiko Mashele1, Leoné Malan, Johannes M van Rooyen
1Hypertension in Africa Research Team (HART), School for Physiology, Nutrition and Consumer Sciences, North-West University, Potchefstroom, South Africa.
Insights
Depression is linked to heart disease risk in African populations. In women, depressive symptoms and metabolic factors contribute to left ventricular hypertrophy (LVH). In men, cardiometabolic factors drive LVH, regardless of depression.
Area of Science:
- Cardiology
- Psychiatry
- Metabolic Syndrome Research
Background:
- Depressive symptoms increase cardiovascular disease risk, often linked to metabolic syndrome (MetS).
- This association requires investigation in African populations.
- Left ventricular hypertrophy (LVH) is a key indicator of cardiac damage.
Purpose of the Study:
- To investigate the association between LVH and MetS risk markers in Black African men and women.
- To explore the role of depressive symptoms in this relationship.
Main Methods:
- Participants were stratified into groups with (D) or without (ND) depressive symptoms.
- Fasting metabolic syndrome markers, glycated hemoglobin (HbA1c), ambulatory blood pressure (BP), and Cornell product-LVH (CP-LVH) via ECG were measured.
- Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria were used for depression assessment.
Main Results:
- Depressive symptoms were present in 45.3% of the sample.
- A pre-diabetic state (HbA1c >5.7%) was observed in both men and women, irrespective of depression status.
- In depressed African women, CP-LVH correlated with lower high-density lipoprotein cholesterol.
- In depressed African men, systolic BP and HbA1c explained significant variations in LVH (64% and 31%, respectively).
Conclusions:
- Depressive symptoms in Black African women are associated with CP-LVH, driven by metabolic factors.
- In Black African men, LVH is primarily driven by cardiometabolic factors like systolic BP and HbA1c, independent of depressive symptoms.
Abstract:
Depressive symptoms are associated with an increased risk for developing cardiovascular diseases, driven by its link to the metabolic syndrome (MetS). This phenomenon, however, still needs to be investigated in the African population. The aim of this study is to investigate the association between left ventricular hypertrophy (LVH) and MetS risk markers in a determined sample. The researchers stratified Black African men and women into with depressive symptoms (D) or without depressive symptoms (ND) group, based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria score. Fasting MetS, chronic hyperglycemia (HbA1c), ambulatory blood pressure (BP) and Cornell product-LVH (CP-LVH) in ECG measures were obtained. Depressive symptoms were reported in 45.3% of the sample. Independent of depression status, African men and women revealed a pre-diabetic state (glycated hemoglobin >5.7%). CP-LVH was associated with decreased low high-density lipoprotein cholesterol in D African women. In D African men, systolic BP (P = .001) and HbA1c (P = .08) explained 64% and 31% of the variation in LVH, respectively. In conclusion, depressive symptoms in Black African women were associated with a measure of target end organ damage, CP-LVH, and this association was driven by a metabolic factor. In Black African men, independent of depressive symptoms, LVH, was driven by cardiometabolic factors, namely SBP and HbA1c.
Related Concept Videos
Coronary Artery Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies

